Division of Geriatrics and Gerontology, Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
J Alzheimers Dis. 2023;94(4):1381-1395. doi: 10.3233/JAD-221287.
Pathological biomarkers of Alzheimer's disease (AD) and other dementias can change decades before clinical symptoms. Lifestyle and health factors might be relevant modifiable risk factors for dementia. Many previous studies have been focusing on associations of lifestyle and health-related factors with clinical outcomes later in life.
We aimed to determine to what extent midlife factors of lifestyle, inflammation, vascular, and metabolic health were associated with long-term changes in blood-based biomarkers of AD (amyloid beta (Aβ)) and neurodegeneration (neurofilament light chain (NfL); total tau(TTau)).
In 1,529 Beaver Dam Offspring Study (BOSS) participants (mean age 49 years, standard deviation (SD) = 9; 54% were women), we applied mixed-effects models with baseline risk factors as determinants and 10-year serum biomarker change as outcomes.
We found that education and inflammatory markers were associated with levels and/or change over time across all three markers of AD and neurodegeneration in the blood. There were baseline associations of measures of cardiovascular health with lower Aβ42/Aβ40. TTau changed little over time and was higher in individuals with diabetes. Individuals with lower risk in a number of cardiovascular and metabolic risk factors, including diabetes, hypertension, and atherosclerosis had slower accumulation of neurodegeneration over time, as determined by NfL levels.
Various lifestyle and health factors, including education and inflammation, were associated with longitudinal changes of neurodegenerative and AD biomarker levels in midlife. If confirmed, these findings could have important implications for developing early lifestyle and health interventions that could potentially slow processes of neurodegeneration and AD.
阿尔茨海默病(AD)和其他痴呆症的病理生物标志物可在临床症状出现前数十年发生变化。生活方式和健康因素可能是与痴呆症相关的可改变的风险因素。许多先前的研究一直关注生活方式和与健康相关的因素与晚年临床结局的关联。
我们旨在确定中年生活方式、炎症、血管和代谢健康因素在多大程度上与 AD(β淀粉样蛋白(Aβ)和神经退行性变(神经丝轻链(NfL);总 tau(TTau))的血液生物标志物的长期变化相关。
在 1529 名 Beaver Dam 后代研究(BOSS)参与者中(平均年龄 49 岁,标准差(SD)=9;54%为女性),我们应用混合效应模型,以基线危险因素为决定因素,以 10 年血清生物标志物变化为结果。
我们发现,教育和炎症标志物与血液中 AD 和神经退行性变的所有三种标志物的水平和/或随时间的变化相关。心血管健康的衡量指标与较低的 Aβ42/Aβ40 之间存在基线关联。TTau 在一段时间内变化不大,在患有糖尿病的个体中较高。患有多种心血管和代谢危险因素(包括糖尿病、高血压和动脉粥样硬化)的个体,随着时间的推移,NfL 水平显示神经退行性变的积累速度较慢。
各种生活方式和健康因素,包括教育和炎症,与中年神经退行性和 AD 生物标志物水平的纵向变化相关。如果得到证实,这些发现可能对开发早期生活方式和健康干预措施具有重要意义,这些干预措施可能会减缓神经退行性变和 AD 的进程。